Open access · CC-BY
via OpenAlex
Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254)
Jonathan B Catterall, Thomas Stäbler, Carl R. Flannery, Virginia B. Kraus
Arthritis Research & Therapy · 2010 · ▲ 257 citations
Abstract
INTRODUCTION: Acute trauma involving the anterior cruciate ligament is believed to be a major risk factor for the development of post-traumatic osteoarthritis 10 to 20 years post-injury. In this study, to better understand the early biological changes which occur after acute injury, we investigated synovial fluid and serum biomarkers. METHODS: We collected serum from 11 patients without pre-existing osteoarthritis from a pilot intervention trial (5 placebo and 6 drug treated) using an intra-articular interleukin-1 receptor antagonist (IL-1Ra) therapy, 9 of which also supplied matched synovial fluid samples at presentation to the clinic after acute knee injury (mean 15.2 ± 7.2 days) and at the follow-up visit for reconstructive surgery (mean 47.6 ± 12.4 days). To exclude patients with pre-existing osteoarthritis (OA), the study was limited to individuals younger than 40 years of age (mean 23 ± 3.5) with no prior history of joint symptoms or trauma. We profiled a total of 21 biomarkers; 20 biomarkers in synovial fluid and 13 in serum with 12 biomarkers measured in both fluids. Biomarkers analyzed in this study were found to be independent of treatment (P > 0.05) as measured by Mann-Whitney and two-way ANOVA. RESULTS: We observed significant decreases in synovial fluid (sf) biomarker concentrations from baseline to follow-up for (sf)C-Reactive protein (CRP) (P = 0.039), (sf)lubricin (P = 0.008) and the proteoglycan biomarkers: (sf)Glycosaminoglycan (GAG) (P = 0.019), and (sf)Alanine-Arginine-Glycine-Serine (ARGS) aggrecan (P = 0.004). In contrast, we observed significant increases in the collagen biomarkers: (sf)C-terminal crosslinked telopeptide type II collagen (CTxII) (P = 0.012), (sf)C1,2C (P = 0.039), (sf)C-terminal crosslinked telopeptide type I collagen (CTxI) (P = 0.004), and (sf)N-terminal telopeptides of type I collagen (NTx) (P = 0.008). The concentrations of seven biomarkers were significantly higher in synovial fluid than serum suggesting release from the signal knee: IL-1β (P < 0.0001), fetal aggrecan FA846 (P = 0.0001), CTxI (P = 0.0002), NTx (P = 0.012), osteocalcin (P = 0.012), Cartilage oligomeric matrix protein (COMP) (P = 0.0001) and matrix metalloproteinase (MMP)-3 (P = 0.0001). For these seven biomarkers we found significant correlations between the serum and synovial fluid concentrations for only CTxI (P = 0.0002), NTx (P < 0.0001), osteocalcin (P = 0.0002) and MMP-3 (P = 0.038). CONCLUSIONS: These data strongly suggest that the biology after acute injury reflects that seen in cartilage explant models stimulated with pro-inflammatory cytokines, which are characterized by an initial wave of proteoglycan loss followed by subsequent collagen loss. As the rise of collagen biomarkers in synovial fluid occurs within the first month after injury, and as collagen loss is thought to be irreversible, very early treatment with agents to either reduce inflammation and/or reduce collagen loss may have the potential to reduce the onset of future post-traumatic osteoarthritis. TRIAL REGISTRATION: The samples used in this study were derived from a clinical trial NCT00332254 registered with ClinicalTrial.gov.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/ar3216
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Catterall, J.B., Stäbler, T., Flannery, C.R., & Kraus, V.B. (2010). Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). <em>Arthritis Research & Therapy</em>. https://doi.org/10.1186/ar3216
Vancouver
Catterall JB, Stäbler T, Flannery CR, Kraus VB. Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). Arthritis Research & Therapy. 2010. doi:10.1186/ar3216.
BibTeX
@article{jonathan2010Change,
title = {Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254)},
author = {Jonathan B Catterall and Thomas Stäbler and Carl R. Flannery and Virginia B. Kraus},
journal = {Arthritis Research & Therapy},
year = {2010},
doi = {10.1186/ar3216},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of California, Los Angeles 2013
Open access · US-GOV
Treatment of Geriatric Depression With Mild Cognitive Impairment: A Double-blind Placebo-Controlled Trial of Namenda (Memantine) Augmentation of Lexapro (Escitalopram) in Depressed Patients at Least 60 Years of Age
The International Journal of Neuropsychopharmacology 2018
Open access · CC-BY
Repeated Systemic Treatment with Rapamycin Affects Behavior and Amygdala Protein Expression in Rats
HARVEST (University of Saskatchewan) 2018
Preprint · OA
Impact of Rapamycin on Genome Organization
2026
Preprint
Lysergic acid diethylamide reverses aging- and neurodegeneration-associated brain transcriptional programs
Future Microbiology 2021
Citation only
Insights into the Gut Microbiome and Its Functional Pathways in Asthma Patients Through High-Throughput Sequencing
medRxiv 2023
Preprint · OA